Deborah C. Langat
Kericho, Kenya
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Prevalence of Chlamydia trachomatis and Neisseria gonorrhoeae Among Adolescents and Adults With Behavioral Vulnerability in Western Kenya.
Journal: Sexually transmitted diseases
Published: August 13, 2025
Knowledge, attitudes and practices related to SARS-CoV-2 prevention in Kenya.
Journal: Journal of public health in Africa
Published: April 09, 2025
Limited awareness and use of HIV post-exposure prophylaxis among people vulnerable to HIV acquisition in Western Kenya: a cross-sectional analysis.
Journal: Journal of the International AIDS Society
Published: September 23, 2024
Pre-exposure prophylaxis implementation gaps among people vulnerable to HIV acquisition: a cross-sectional analysis in two communities in western Kenya, 2021-2023.
Journal: Journal of the International AIDS Society
Published: April 01, 2024
Mortality and Associated Risk Factors Among People Living With HIV With Kaposi Sarcoma: A5263/AMC066 and A5264/AMC067.
Journal: Journal of acquired immune deficiency syndromes (1999)
Published: January 19, 2024
Effectiveness of Double-Dose Dolutegravir in People Receiving Rifampin-based Tuberculosis Treatment: An Observational, Cohort Study of People With HIV From 6 Countries.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: January 03, 2024
Predictive Value of Serum Biomarkers for Response of Limited-Stage AIDS-Associated Kaposi Sarcoma to Antiretroviral Therapy With or Without Concomitant Chemotherapy in Resource-Limited Settings.
Journal: Journal of acquired immune deficiency syndromes (1999)
Published: April 03, 2023
Population Pharmacokinetic Modeling and Simulation of Rifapentine Supports Concomitant Antiretroviral Therapy with Efavirenz and Non-Weight Based Dosing.
Journal: Antimicrobial agents and chemotherapy
Published: August 09, 2022
Isoniazid Adherence Reduces Mortality and Incident Tuberculosis at 96 Weeks Among Adults Initiating Antiretroviral Therapy With Advanced Human Immunodeficiency Virus in Multiple High-Burden Settings.
Journal: Open forum infectious diseases
Published: March 16, 2022
Higher Dose Oral Fluconazole for the Treatment of AIDS-related Cryptococcal Meningitis (HIFLAC)-report of A5225, a multicentre, phase I/II, two-stage, dose-finding, safety, tolerability and efficacy randomised, amphotericin B-controlled trial of the AIDS Clinical Trials Group.
Journal: PloS one
Published: September 29, 2021
Pharmacokinetics and Safety of 3 Months of Weekly Rifapentine and Isoniazid for Tuberculosis Prevention in Pregnant Women.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: February 02, 2021
Nevirapine pharmacokinetics in HIV-infected persons receiving rifapentine and isoniazid for TB prevention.
Journal: The Journal of antimicrobial chemotherapy
Published: July 01, 2020
Last Updated: 09/26/2026